Fahad Alqahtani, MD د.فهد القحطاني
@fsqmd2
استشاري تخصص دقيق - البورد والزمالة الامريكيه في تخصص الباطنه والقلب و القسطرة و الصمامات- مختص في علاج الصمام الميترالي والثلاثي interventional cardiologist
ID: 1531314508098068482
https://www.researchgate.net/profile/Fahad_Alqahtani5/info 30-05-2022 16:40:15
271 Tweet
617 Followers
121 Following
Cost effectiveness analysis Work led by Andrew Sharp and his team showing an IVUS-guided PCI strategy was highly cost-effective over angiography alone amongst ACS patients undergoing DES implantation due to the medium- and long-term reduction in repeat PCI, death, and MI
Moderate/severe TR raises #HeartFailure & #CVdeath risk in #HFrEF patients, highlighting the need for TR management. This study also shows that omecamtiv mecarbil’s effectiveness remains unaffected by TR severity. bit.ly/4cc8kGk #JACCHF Marianna Adamo Marco Metra
New JACC Journals SOTA on TR Management Pre-TTVI. bit.ly/3VMKtao also see: bit.ly/TVARC Mack Eleid Joann Lindenfeld jörg hausleiter Philipp Lurz
مشاركتنا اليوم وتمثيل الجمعية الخليجية للقسطرة القلبية Gulf Intervention Society - GIS وبمشاركات متنوعة ومميزة عن احدث التطورات في علاج الصمام الميترالي بالقسطرة ، المشبك او التدخل الجراحي البسيط Representing Gulf Intervention Society - GIS at Jordan valve. Variety of cases and advances in transcatheter Mitral intervention
Functional TR distinctions? This meta-analysis reveals higher mortality with right ventricular dysfunction, suggesting a differential prognosis between atrial and ventricular functional #vhdTR. bit.ly/3Wjk97t #JACCIMG #echofirst Anna Sannino MD PhD FASE Sara Bombace
In the bRIGHT study, tricuspid #TEER with #TriClip is safe and effective through 1-yr for significant TR in a real-world population bit.ly/4bEVbEE #JACC #vhdTR Univ.-Prof. Dr. Ralph Stephan von Bardeleben Karl-Philipp Rommel